Zoetis to give exclusive update at Superbugs USA congress this fall

ISELIN, NEW JERSEY, UNITED STATES, August 30, 2016 /EINPresswire.com/ -- SMi Group are thrilled to have Dr Mahesh Kumar, Vice President of Global Biological and Development from Zoetis, provide a DAY 2 opening keynote address at the Superbugs & Superdrugs USA conference when it arrives to Iselin, New Jersey this fall.

With almost 30 years of experience, Dr Mahesh Kumar has developed several key vaccines in E. coli and avian influenza with global approval for use against the Asian H5N1 strain. He has several publications in avian health and has invented several patents.

He currently serves as the Vice President of Global Biologics R&D responsible for the development of biologics in all species including vaccines against emerging infectious diseases at Zoetis - Pfizer’s animal health division spin off.

75 percent of diseases that can affect people are zoonotic, meaning they can transmit between animals and people.* With a focus on zoonotic infectious diseases, Dr Kumar will provide delegates at Superbugs & Superdrugs USA with exclusive insight on becoming first to know about emerging diseases with further guidance into fast market entry.

Other notable speakers will include:

• Dr Pilar Ramon-Pardo, Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
• Dr Christopher Houchens, Branch Chief, Antibacterials Program, BARDA
• Dr Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, DMID, NIAID, NIH
• Dr John Rex, Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca
• Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer
• Dr Anthony Simon Lynch, Senior Scientifi c Director, Janssen Research & Development LLC
• Scott Coleman, Head of Nonclinical Development, Spero Therapeutics

Further details are available online at www.superbugs-usa.com

Superbugs & Superdrugs USA
November 14th & 15th 2016
Renaissance Woodbridge Hotel, Iselin, New Jersey
Sponsored by Noigel, LLC and Polyphor
http://www.superbugs-usa.com

Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
To register for the conference, visit http://www.superbugs-usa.com or contact Matthew Apps on Tel: +44 (0)20 7827 6093 / Email: mapps@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

---END---

*Source: https://www.zoetis.com/news-and-media/feature-stories/posts/combating-infectious-diseases.aspx

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group
2078276000
email us here